An Open-Label, Randomised, Multicentre, Phase III Study of Irinotecan Liposome Injection, Oxaliplatin, 5-fluorouracil/Leucovorin Versus Nab-paclitaxel Plus Gemcitabine in Subjects Who Have Not Previously Received Chemotherapy for Metastatica

Grants and Contracts Details

StatusActive
Effective start/end date3/24/201/11/25

Funding

  • Medpace Inc: $98,616.00